We are live on ! Find out more
Mariner

Mariner Portfolio holdings

AUM $85.7B
1-Year Est. Return 24.21%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$77.4B
AUM Growth
+$8.11B
Cap. Flow
+$3.32B
Cap. Flow %
4.29%
Top 10 Hldgs %
28.04%
Holding
3,806
New
339
Increased
1,836
Reduced
1,278
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Financials 7.9%
3 Consumer Discretionary 5.38%
4 Communication Services 4.83%
5 Healthcare 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRTSW icon
3476
Alpha Tau Medical Warrant
DRTSW
$74.4M
$32.4K ﹤0.01%
93,888
NFE icon
3477
New Fortress Energy
NFE
$101M
$30.9K ﹤0.01%
+14,000
New +$39.8K
ACRS icon
3478
Aclaris Therapeutics
ACRS
$730M
$30.6K ﹤0.01%
16,112
-4,898
-23% -$8.54K
BLNK icon
3479
Blink Charging
BLNK
$75.2M
$30.6K ﹤0.01%
18,641
-941
-5% -$1.05K
CLNE icon
3480
Clean Energy Fuels
CLNE
$447M
$29.8K ﹤0.01%
11,566
-97
-0.8% -$227
TCRX icon
3481
TScan Therapeutics
TCRX
$51.9M
$29.2K ﹤0.01%
16,031
-1,023
-6% -$1.81K
ORMP icon
3482
Oramed Pharmaceuticals
ORMP
$165M
$29.1K ﹤0.01%
11,021
+935
+9% +$2.07K
JSPR icon
3483
Jasper Therapeutics
JSPR
$22.9M
$29K ﹤0.01%
12,193
-13,320
-52% -$40.4K
FATE icon
3484
Fate Therapeutics
FATE
$281M
$28.9K ﹤0.01%
22,930
+11,393
+99% +$12.3K
NKTX icon
3485
Nkarta
NKTX
$162M
$28.2K ﹤0.01%
13,609
+505
+4% +$1.04K
EXFY icon
3486
Expensify
EXFY
$166M
$28.1K ﹤0.01%
15,163
+5,155
+52% +$10.4K
OLPX
3487
DELISTED
Olaplex Holdings
OLPX
$28K ﹤0.01%
+21,404
New +$30.7K
TELO icon
3488
Telomir Pharmaceuticals
TELO
$79.1M
$27.8K ﹤0.01%
+19,994
New +$30.2K
GTEC icon
3489
Greenland Technologies Holding
GTEC
$13.6M
$27.2K ﹤0.01%
+20,596
New +$32K
IAUX
3490
i-80 Gold Corp
IAUX
$1.17B
$25.9K ﹤0.01%
27,084
+2,635
+11% +$1.92K
CHGG icon
3491
Chegg
CHGG
$108M
$25.6K ﹤0.01%
16,983
-4,665
-22% -$6.56K
LAB icon
3492
Standard BioTools
LAB
$326M
$25.6K ﹤0.01%
19,670
-8,521
-30% -$11.2K
INMB icon
3493
INmune Bio
INMB
$43.1M
$25.5K ﹤0.01%
12,331
+1,452
+13% +$3.32K
CAN
3494
Canaan Creative
CAN
$176M
$25.4K ﹤0.01%
28,785
+7,100
+33% +$5.39K
KOPN icon
3495
Kopin
KOPN
$663M
$24.3K ﹤0.01%
10,000
HAIN icon
3496
Hain Celestial
HAIN
$47.8M
$24K ﹤0.01%
15,203
+2,601
+21% +$4.43K
BFLY icon
3497
Butterfly Network
BFLY
$1.72B
$23.2K ﹤0.01%
12,007
+7
+0.1% +$12
SID icon
3498
Companhia Siderúrgica Nacional
SID
$1.43B
$23K ﹤0.01%
15,311
-30,800
-67% -$44.4K
MIRA icon
3499
MIRA Pharmaceuticals
MIRA
$37.1M
$22.4K ﹤0.01%
16,500
TLPH icon
3500
Talphera
TLPH
$70.1M
$22.3K ﹤0.01%
+25,000
New +$14.5K

Similar funds

Mariner's Q3 2025 Portfolio in Review

As of Q3 2025, Mariner held 3,806 positions worth $77.4B, up 12% from $69.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Mariner deployed $3.32B of net new capital in Q3 2025, opening 339 new positions and adding to 1,836 existing holdings. Its largest new stake was ProShares Ultra Semiconductors: 17,808,292 shares worth $8.97M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Take-Two Interactive, an estimated $189M trimmed.

  • Mariner's largest Q3 2025 buy was ProShares Ultra Semiconductors: 17,808,292 shares worth $8.97M.
  • Mariner added most to NVIDIA in Q3 2025, an estimated $373M increase.
  • Mariner's biggest Q3 2025 reduction was Take-Two Interactive, cutting an estimated $189M.
  • Mariner fully exited Hess in Q3 2025, selling an estimated $5.21M.
  • Mariner's ten largest holdings make up 28% of its $77.4B portfolio in Q3 2025.
  • Mariner opened 339 new positions and closed 264 in Q3 2025.
  • Mariner's portfolio value rose 12% quarter-over-quarter to $77.4B.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.